The present study aims at evaluating the expression of CEACAM1 in lung diseases and the profiling of CEACAM1 isoforms and PI3K subtypes after IFN-γ treatment, and investigating the role of PI3K pathway in IFN-γ-induced CEACAM1 expression in airway epithelial cells. Here, IFNG is linked to lung disorder.